Published in

Wiley, Hepatology Research, 1(52), p. 105-119, 2021

DOI: 10.1111/hepr.13720

Links

Tools

Export citation

Search in Google Scholar

Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity

Journal article published in 2021 by Takayuki Tokunaga ORCID, Masakuni Tateyama, Kentaro Tanaka, Satoshi Narahara, Hiroki Inada ORCID, Sotaro Kurano, Sanae Hayashi ORCID, Yoko Yoshimaru, Katsuya Nagaoka, Takehisa Watanabe, Hiroko Setoyama, Motohiko Tanaka, Yasuhito Tanaka ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO